Skip to content
Clinical Trials – home
OncoVerity Inc.
Sponsor

OncoVerity Inc.

United States 12635 East Montview Boulevard, 80045-7335, United States

About the sponsor

OncoVerity Inc. focuses on clinical research in acute myeloid leukemia, with studies centered on newly diagnosed patients who are not candidates for intensive chemotherapy. The sponsor’s trial portfolio includes combination approaches built around azacitidine and other background therapies for this hematologic malignancy.

  • Newly diagnosed AML
  • Non-intensive treatment settings
  • Hematologic oncology

The research activity reflects a strong interest in treatment options for patients requiring less intensive therapeutic strategies in blood cancer care.

About Specializations

OncoVerity Inc. runs clinical trials in conditions such as Acute myeloid leukaemia, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study on Venetoclax, Azacitidine, and Cusatuzumab for Newly Diagnosed Acute Myeloid Leukemia Patients Not Suitable for Intensive Therapy

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:OncoVerity Inc.

Study of Cusatuzumab and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:OncoVerity Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.